ArticleMolecular cancer therapeutics2024

Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.

Funda Meric-Bernstam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.